Study: NCT05829655

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Drug A (Blinded Drug)
Description: Participants will receive a double-blinded oral study medication as part of their daily sessions and will provide feedback regarding the effects of the medication on various measures. Though the study medications are FDA approved, they are being used here for a non-FDA approved purpose (though the FDA has provided permission to use these drugs in this study).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drug A (Blinded Drug)
Description: Participants will receive a double-blinded oral study medication as part of their daily sessions and will provide feedback regarding the effects of the medication on various measures. Though the study medications are FDA approved, they are being used here for a non-FDA approved purpose (though the FDA has provided permission to use these drugs in this study).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Drug B (Blinded Drug)
Description: Participants will receive a double-blinded oral study medication as part of their daily sessions and will provide feedback regarding the effects of the medication on various measures. Though the study medications are FDA approved, they are being used here for a non-FDA approved purpose (though the FDA has provided permission to use these drugs in this study).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drug B (Blinded Drug)
Description: Participants will receive a double-blinded oral study medication as part of their daily sessions and will provide feedback regarding the effects of the medication on various measures. Though the study medications are FDA approved, they are being used here for a non-FDA approved purpose (though the FDA has provided permission to use these drugs in this study).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Drug C (Blinded Drug)
Description: Participants will receive a double-blinded oral study medication as part of their daily sessions and will provide feedback regarding the effects of the medication on various measures. Though the study medications are FDA approved, they are being used here for a non-FDA approved purpose (though the FDA has provided permission to use these drugs in this study).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drug C (Blinded Drug)
Description: Participants will receive a double-blinded oral study medication as part of their daily sessions and will provide feedback regarding the effects of the medication on various measures. Though the study medications are FDA approved, they are being used here for a non-FDA approved purpose (though the FDA has provided permission to use these drugs in this study).

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Drug D (Blinded Drug)
Description: Participants will receive a double-blinded oral study medication as part of their daily sessions and will provide feedback regarding the effects of the medication on various measures. Though the study medications are FDA approved, they are being used here for a non-FDA approved purpose (though the FDA has provided permission to use these drugs in this study).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drug D (Blinded Drug)
Description: Participants will receive a double-blinded oral study medication as part of their daily sessions and will provide feedback regarding the effects of the medication on various measures. Though the study medications are FDA approved, they are being used here for a non-FDA approved purpose (though the FDA has provided permission to use these drugs in this study).